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1. Introduction
The advance of high throughput technologies has considerable implications for research in the areas
of cancer detection and prevention. In a gene expression array experiment, the expression levels
of thousands of genes are monitored simultaneously. Such exploratory studies promise to identify
transcripts that show high expression levels in cancer tissues as compared to normal tissues, to
pinpoint the biological processes for cancer at the most basic level, and to discover cDNAs encoding
proteins that could be potentially useful markers for cancer screening and diagnosis.
Typically, microarray experiments involve exploring enormous numbers of genes on a relatively
small set of subjects. For example, in a study concerning gene expression profiling and clinical
outcome of breast cancer (Van ’t Veer et al., 2002), tumor tissue from 34 patients who developed
distant metastases within 5 years and 44 patients who were free of disease for at least 5 years were
analyzed to compare the hybridizations on an array of 25,000 cDNAs. Statistical analysis of data from
such studies is challenging for several reasons. First, when thousands or tens of thousands of genes
are under consideration from a single experiment, performing separate significant tests for each gene
greatly increases the type I error. Second, the expression levels of genes tend to cluster as they may
function on the same biological pathways and thus co-regulate under the experimental conditions
examined. As a consequence, the test statistics can be far from independent. Third, because of
concerns about cost or rarity of the target population, a microarray study is usually carried out on
a small number of subjects. In this situation the underlying distributional assumptions for the test
statistics, which are based on large sample theory, may not be valid or precise enough. It is essential
to take into account these problems in the analysis of data.
It is also important to recognize that an appropriate statistical approach depends on the scientific
objectives of the study. In this article, we consider microarray studies that are aimed to explore a
large pool of genes and select for more careful investigation a subset of genes that are differentially
expressed in two tissue types (e.g., cancer versus healthy tissue). In practice, the gene selection
process entails several steps. As an initial step, one needs to characterize the capacity of each gene
in discriminating between the different tissue types. The choice of statistic is crucial to the entire
process. The classic measure of discrimination, such as the two-sample t-statistic or the Mann-
1
Hosted by The Berkeley Electronic Press
Whitney U-statistic are often considered at this stage. Two additional measures that are related to
the Receiver Operating Characteristic (ROC) curve are suggested in Pepe et al. (2003) when there is
emphasis on the discriminating capacity over a particular range of the distribution. Once the statistic
for discrimination is calculated for each gene, the next step towards selecting genes is to rank the
genes based on their evidence for differential expression. At the final stage, one chooses to further
investigate the genes that rank well, for example, one might narrow down future research to the top
k ranking genes. One important question at this stage is what subset of genes should be selected, i.e.,
at what k should one draw the line so that the selection process is statistically more rigorous than
just choosing some arbitrary k?
In this article we focus on statistical methods for this question. Note that we are not concerned
with combining information across genes, a consideration that may or may not follow the analysis
that simply ranks the genes. Our focus is on determining a set of genes that each appear to be
differentially expressed. In section 2, we first review existing statistical methods that can be adopted
for gene selection and then describe a new approach. We compare the performance of our proposed
approach with the existing methods using simulation studies in section 3. We further illustrate our
new approach with an application to the breast cancer data and close in section 5 with some remarks
about the methodology.
2. Selecting Genes
2.1 Existing Methods
Statistical methods for microarray analysis has been a burgeoning area of statistical research in recent
years (for review, see Dudoit, Shaffer, Boldrick (2002)). The problem of identifying differentially
expressed genes can be translated into the framework of multiple hypothesis testing, where each gene
corresponds to a single hypothesis test, and rejecting one hypothesis is equivalent to claiming that
the gene is differentially expressed. Table 1 describe the situation when m genes (or hypotheses) are
tested. We suppose m0 of the m genes are not differentially expressed, or are true null hypotheses.
We denote by R the number of rejected hypothesis, V the number of false positives, and T the number
of false negatives. Only m and R are observable quantities.
An appropriate test procedure should aim to keep both V (the type I error) and T (the type II
2
http://biostats.bepress.com/uwbiostat/paper223
error) small. In the univariate setting, the usual strategy is to first prespecify an acceptable type I
error α, then seek a test with the most power (smallest type II error) among the class of tests with
the same α. To generalize to the multivariate setting, the approach is to define a multiple testing
procedure in terms of the adjusted p-value p˜j for hypothesis j, which takes all other tests that are
involved into consideration, rather than the individually unadjusted p-value pj. One then rejects Hj
if p˜j ≤ α. The adjusted p-values are usually derived in such a way that some type I error rate is
controlled at level α.
One type I error rate, the family-wise error rate (FWER), is defined as
FWER = P [V ≥ 1]. (1)
It is the probability of reporting at least one false positive in the family of hypotheses. The step-down
algorithm of Westfall and Young (1993) is an example of a multiple testing procedure that controls
FWER. The procedure defines the jth adjusted p-value as p˜j = P [min1≤l≤mPl ≤ pj |Hc0]. Here Hc0
denotes the complete null hypothesis, where all the null hypotheses are true (i.e., m = m0) and
Pl is the unadjusted p-value for the lth hypothesis denoted with capital letter here because it is a
random variable. The joint distribution of (P1, ..., Pm) can be estimated by permuting the columns
of the gene by array data matrix. This algorithm thus takes into account the potential dependence
structure amongst genes. Compared with the popular Bonferroni procedure, the approach is less
conservative.
Benjamini and Hochberg (1995) suggested a multiple testing procedure that aimed to control a
different type I error rate, namely, the false discovery rate (FDR). In their definition,
FDR = E(V/R|R > 0)P (R > 0) (2)
The concept of FDR is appealing in the context of gene discovery for several reasons. First, FDR
has a straightforward interpretation. It is the expected proportion of false positives among genes
for which H0 is rejected, and approximately, it is P [H0|rejected] since P [R = 0] is typically small.
In many applications it can be less stringent than controlling FWER. More importantly, when the
goal of a microarray study is to narrow down to a small subset of genes as potential candidates
for scrutinization in the next stage of research, one can usually tolerate a small number of false
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positives in exchange for higher power. Controlling FDR directly translates into controlling the
amount of unnecessary effort invested in a few false positives in the next stage of gene discovery.
several procedures have been proposed to control FDR. For example, Benjamini and Hochberg (1995)
described a linear step-up procedure. Suppose we order the unadjusted p-values as p(1) ≤ p(2) . . . ≤
p(m), with corresponding ordered null hypotheses H(1), H(2), . . ., H(m). The adjusted p-value for
H(j) is p˜BH(j) = mink=j,...m
{
min(mk p(k), 1)
}
. We reject H(1), . . . ,H(k) for k = max{j : p˜BH(j) ≤ α}
for a desired FDR level α. It can be shown that for independent and continuous test statistics, the
procedure yields FDR = α ∗ m0/m, which is ≤ α. Furthermore, the same level of FDR control
holds for positively dependent test statistics as well in the sense defined by Benjamini and Yekutieli
(2001). One example of positive dependency structure is positively correlated normally distributed
test statistics. When m0/m is substantially smaller than 1, it is tempting to consider an adaptive
procedure so FDR is controlled exactly at level α. For example, Storey (2002) suggested to first
estimate m0, and reject H(1), . . . ,H(k) for k = max{j : p˜BH(j) ∗ mˆ0/m ≤ α}. To estimate m0, Storey
suggests the following procedure
m̂0(λ) =
Σmi=1I{pi ≥ λ}
1− λ , (3)
where λ is in the interval (0, 1) and can be chosen using cross-validation, for example. The adaptive
procedure is usually more powerful because it is less conservative, being based on the bound mmˆ0α
rather than α for p˜BH(j) .
Different from the multiple testing procedures described above, the SAM (significance analysis of
microarrays) procedure (Efron et al., 2000, Tusher et al., 2001) chooses rejection regions from the
distributional properties of the test statistics. The original SAM procedure proposed by Efron et
al. (2000) makes use of the ordered test statistics t(1) ≥ t(2) . . . ≥ t(m) and a resampling technique.
Under the assumption that none of the genes is truly differentially expressed, the labeling of the two
groups, cases and controls, can be interchanged. One performs B permutations of the labels and
obtains t(j),b for b = 1, . . . , B. The expected value t¯(j) for the jth order statistic under Hc0 can then
be estimated based on the permuted samples. For a fixed threshold ∆, genes with |t(j)− t¯(j)| ≥ ∆ are
claimed significant by the SAM procedure. The SAM procedure can be tailored to control FDR∗,
a quantity similar to the FDR that is defined above. This requires estimating the FDR∗ for each
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∆ from the permutation samples under Hc0 (Storey, 2002) and then choosing the ∆ that yields the
desired FDR∗ level. The strength of the approach is that it offers great flexibility in choosing rejection
regions while controlling for FDR∗ at a desired level. However, the procedure is based on the implicit
assumption that the distributions of t(j) − t¯(j) are homogenous. Furthermore, the procedure controls
FDR∗ = E(V |Hc0)/R, which is not the same as the FDR as originally defined by Benjamini and
Hochberg (1995).
2.2 The AP Method
We propose a new multiple hypothesis testing procedure here. Consider calculating the following
adjusted p-value for the kth ordered gene: p∗(k) = P [|T 0|l ≥ |t(k)||Hc0, l ≤ k]. This is the probability
underHc0 of observing a statistic as extreme or more extreme than the observed kth order statistic t(k)
among the top k order statistics T 0(l), l ≤ k. In calculating p∗(k), T 0(l) is a random variable for t(l) under
Hc0. The proposal is to declare genes whose adjusted p-values are ≤ α as significant (details below).
The idea has some intuitive appeal in our opinion. Given the observed order statistic t(k), it asks
how likely it is that under the complete null hypothesis Hc0 the test statistic for genes (1), (2), ..., (k)
would exceed t(k). The quantity p∗(k) calibrates t(k) to the distributions of the order statistics under
Hc0. This seems like a natural step. It is similar to SAM in this regard. However, SAM rejects on the
basis of |t(j) − t¯(j)| with a cut-off ∆, that is the same for all genes. Our procedure on the other hand
acknowledges that the distribution of T 0(j) may not be symmetric about its mean and that its variance
may depend on the order (j). Moreover, we will show in section 3 that the operating characteristics
of our procedures are comparable (and sometimes better than) existing procedures. We suggest
estimating p∗(k) using a resampling procedure to avoid assumptions about the joint distribution of test
statistics and to take into account the potential dependence structure amongst genes. In summary,
implementation of our procedure consists of the following steps:
1. Compute the order statistics t(1) ≥ t(2) · · · ≥ t(m).
2. Perform B permutations of the group labels and obtain t(j),b for each permutation sample b.
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3. Compute
p∗(k) =
1
B
B∑
b=1
1
k
k∑
l=1
I(|t(l),b| ≥ |t(k)|) (4)
4. Monotonize the p-values: p˜(j) =mink=j,...m
{
min(p∗(k), 1)
}
5. Reject H(j) if p˜(j) ≤ some chosen α.
3. Simulation Study
We present the results from numerical studies in this section.
3.1 Compare the proposed AP procedure with SAM
We first evaluate the performance of our resampling-based p-values procedure (hereafter referred to
as AP) with SAM, as both procedures make use of the distributions of the order statistics under
Hc0. We generated m = 500 gene expression values X1, · · · , Xm for n0 control and n1 case subjects.
For the small sample study, we chose n0 = n1 = 20 and for the moderate sample study we choose
n0 = n1 = 50. We set equal numbers of true null and alternative hypotheses, i.e., m0 = 50%m.
Two scenarios for generating expression levels of different genes were used. In the first scenario,
Xk ∼ N(0, σ0) with σ0 ∼ N(1, 0.5), for k = 1, . . . ,m for controls and for k = 1, . . . ,m0 for cases.
For cases the expression levels of regulated genes Xk, k = m0 + 1, . . . ,m are generated as Xk ∼
N(2.0, σ1), where σ1 ∼ N(1.5, 0.5). Although we allow some variation in terms of dispersion of the
distributions of different genes, these distributions still come from the same location-scale family and
are symmetric. In the second scenario, we used gamma distributions for generating the expression
data. The gene expression values for all m genes of controls and m0 null genes for cases are specified
as Xk ∼ γ(1, 1), and the expression levels of regulated genes for cases are generated as Xk ∼ γ(2, 0.8),
k = m0 + 1, . . . ,m. Thus in this scenario we assume genes expression levels are not symmetrically
distributed.
For each simulation configuration, we generated S = 500 datasets and performed both our pro-
posed procedure and the SAM procedure. The two-sample test statistic we used to gauge differential
expression is the Mann-Whitney U-statistic (denoted by AUC) or equivalently the Wilcoxon ranksum
statistic. The SAM procedure is therefore slightly different from the original algorithm of Tusher
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et al.(2001). For each dataset, we first calculate AUC for each gene and order them as AUC(1),
AUC(2),. . ., AUC(m). We then take B = 1000 permutations of the group labels. For each permuta-
tion b we obtain the corresponding ordered AUC statistics: AUCb(1), AUC
b
(2),. . ., AUC
b
(m). For the
SAM procedure, we calculate dj = |AUC(j) − AUCB(j)| for the jth ordered AUC, where AUCB(j) is
the average of AUCb(j) across the B permutation samples. We reject the corresponding jth gene if
the value of dj exceeds some prespecified quantity, ∆. For AP, we calculate the adjusted p values
for the ordered genes based on the same permutation samples using the procedure as described in
the previous section, and reject a gene if the adjusted p value is less than a prespecified value, α.
For each dataset s and each procedure, we record Rs, the number of genes that are claimed to be
differentially expressed, and Vs, the number of genes rejected among all the genes that are in truth
not differentially expressed. Let Qs = Vs/Rs if Rs 6= 0, and 0 if Rs = 0, we then calculate FDR as
FDR =
1
S
S∑
s=1
Qs, (5)
and average power as
Power =
1
S
S∑
s=1
Rs − Vs
m−m0 , (6)
where (Rs − Vs)/(m −m0) is the proportion of differentially expressed genes that are claimed to be
significant. Note that the average power is equivalent to the true positive rate (TPR). In addition,
we record the false positive rates (FPR) as
FPR =
1
S
S∑
s=1
Vs
m0
, (7)
Decision criteria for the AP and the SAM procedures are defined by thresholds, α and ∆ respec-
tively, that are on completely different scales. To compare the performances of the two procedures
we therefore use ROC curves. That is, for each procedure, we plot TPR versus FPR as the threshold
varies across its entire possible range. The ROC curve is a one-one monotone function from (0, 1) to
(0, 1) that is a well accepted measure for comparing decision procedures. Better decision procedures
are characterized by higher ROC curves. For n0 = n1 = 20, if the gene expression levels are of gamma
variates, the ROC curve based on the adjusted p-values from the AP procedure dominates the curve
based on the SAM procedure (Figure 2, top left panel), especially over the region where FP is less
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than .2. This indicates that for this particular simulation configuration, the AP procedure has higher
accuracy at distinguishing between cases and controls than the SAM procedure. Furthermore, plots
of average power versus FDR (Figure 2, top right panel) again show that AP is a more powerful
procedure than SAM for this simulation configuration. For example, with FDR of 0.05, the average
power is 0.71 for AP, compared with 0.45 for SAM; for FDR at 0.1, the average power is 0.86 for
AP but 0.81 for SAM. However, these differences are not observed in the simulation situation where
samples are generated solely from normal distributions (Figure 1). In addition, the superior perfor-
mance of AP over SAM diminishes at moderate sample size such as n0 = n1 = 50 (bottom panels,
Figure 1 and Figure 2) . These results may not be too surprising. A possible explanation is that
SAM assumes homogenous and symmetric distributions of test statistics for all genes and that this an
assumption is more likely violated with smaller sample sizes. On the other hand, the AP procedure
naturally incorporates the variation in the distribution of the test statistic from gene to gene, and
does not require any specific distributional assumption. It is thus a more robust and more powerful
procedure, particularly in small samples.
3.2 Controlling FDR and power
We next compare the performance of the AP procedure with multiple testing procedures that proposed
to control the FDR. We investigate to what extent factors such as the dependency structure and
number of genes impact on the performance as measured by the FDR and average power.
We generate m = 40, 200, 1000 gene expression values. For the small sample study, we choose
n0 = n1 = 20 and for the moderate sample we choose n0 = n1 = 50. We consider different numbers
of true null hypotheses m0 with m0 = 50%m, 75%m, or 90%m. The gene expression values are
specified as Xk ∼ N(0, 1), k = 1, . . . ,m for controls and k = 1, . . . ,m0 for cases, while Xk has a
mixture distribution with p = .7, and Xk ∼ (1 − p) ∗ N(0, 1) + p ∗ N(1, 2), k = m0 + 1, . . . ,m for
cases. The gene expression values are correlated in groups of 10. Specifically, within each cluster of
10 consecutive genes, we let the correlations among the first five genes and the correlations among the
second five genes (denote by r1) be positive, however the correlation between the first 5 genes and the
second 5 genes (denote by r2) can be either positive or negative. In summary we consider the following
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correlation structures: (r1 = 0, r2 = 0), (r1 = 0.3, r2 = 0.3), (r1 = 0.3, r2 = −0.3), (r1 = 0.6, r2 = 0.6),
(r1 = 0.6, r2 = −0.6), When the correlations are negative, the ‘positive dependence’ condition of
Benjamini and Yekutieli (2001) does not hold. For each gene k, we calculate the test statistics AUCk
from theXk for the n0 cases and n1 controls. For each simulation configuration, S = 500 datasets were
generated. We implemented the linear step-up procedure (hereafter referred to as BH), the adaptive
procedure (hereafter referred to as Adapt) with λ = 0.5 and our resampling-based AP procedure. We
did not consider the SAM procedure in this set of simulation studies since SAM controls a different
FDR than do the other procedures.
First consider a small sample study with 20 cases, 20 controls and 40 genes. Figure 3 displays
FDR versus threshold (α) for studies with different correlation structures and different numbers of
true null hypotheses m0. For the BH procedure, the FDRs are less than α in all cases, and they get
closer to α as the percentage of the true null hypotheses increases. In fact, they are very close to the
value m0m α. This is consistent with the theoretical result which states that the FDR is controlled at
level m0m α for continuous and positively dependent test statistics. Interestingly, even in situations with
both positive and negative correlations, where the positive dependence requirement is not satisfied,
it appears the BH procedure still controls FDR at a level that is comparable with level of control
achieved for positive dependence situations. For our AP procedure, the FDRs are higher than those
from the BH procedure, but less than the threshold α for m0/m ≤ 75%. Furthermore, the FDRs
from the AP procedure increase as the number of the null hypotheses increase, as was seen for the
BH procedure. The FDR exceeds α in the setting where m0/m = 90%. Thus the AP procedure
does not necessarily control the FDR (nor was it intended to). For the adaptive procedure, the
FDRs are almost always higher than for the other two procedures, particularly when m0/m is small.
In contrast to the AP and BH procedures, the adaptive procedure is sensitive to the underlying
correlation structure. When the genes are statistically independent, the FDRs from the adaptive
procedure are close to the corresponding α. However, when genes are positively correlated, we see in
many cases that the attained FDR is often greater than the corresponding α at which it wishes to
control the FDR. When genes are both positively and negatively correlated, the adaptive procedure
seems to underestimate m0 and thus the FDRs tend to be lower than α. A possible explanation for
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this is that the weak dependence assumption required for the adaptive procedure probably does not
hold when the number of genes is small.
Corresponding to the configurations in Figure 3, Figure 4 shows average power versus threshold.
In general, the adaptive procedure is more powerful than the other two procedures, particularly in
settings where the number of true null genes are small. Moreover, the AP procedure is always more
powerful than the BH procedure. However the advantage of the adaptive procedure diminishes when
the majority of the genes are not differentially expressed in truth. For example, when m0 = 75%m,
the AP procedure is at least as powerful as the adaptive procedure.
Similar patterns are found in a study with the same number of genes but bigger sample sizes,
n0 = n1 = 50, and in studies with larger numbers of genes: m=200 (see Table 2, Table 3, Table 4),
and m = 1000 (data not shown). As the number of genes increases, the adaptive procedure better
estimates m0/m, but still seems to be problematic when genes are both negatively and positively
correlated.
One phenomenon we observed from our simulation studies as well as from the literature is that
a procedure with higher FDR is usually more powerful. This may simply result from its using a less
stringent criterion for declaring a gene to be significant. Ideally a procedure should be compared
against the class of procedures that controls FDR at the same level. To compare the powers of
the three multiple testing procedures when operating at the same FDR levels (and here at different
thresholds α), we plot average power as a function of FDR. In Figure 5, we use data from the
simulation studies with correlation structure r1 = 0.6, r2 = −0.6 for m = 200 and m = 1000. It
appears that for each value of m0/m the operating characteristics of the three procedures lie on a
single curve. That is for the three testing procedures we considered in the simulation studies, the
same power can be achieved if we are willing to tailor the threshold so the same level of FDR is
achieved. Furthermore, the figure suggests that there may exist a fundamental relationship between
FDR and average power for a given data structure, regardless of the multiple testing procedure that
one chooses, or the total number of genes in the pool.
In summary, the simulation studies demonstrate that the three procedures differ in regards to their
attained FDR when the same thresholds α is applied to each. However, they have the same trade-off
10
http://biostats.bepress.com/uwbiostat/paper223
between increasing FDR and increasing average power, so in this sense they are not fundamentally
different in their operating characteristics. Nevertheless in practice one needs to specify α and proceed
with selecting genes accordingly. The adaptive procedure is attractive because it is least conservative
(and hence more powerful) since it seeks to control FDR at a level close to α. However, the adaptive
procedure assumes the same conditions as those of BH, and requires m0/m be well estimated. Thus
for some correlation structures we found that the actual FDR of the procedure can exceed the nominal
level. This may be worrisome in applications. The new AP procedure does not make any distributional
assumptions and is strikingly more powerful than the BH procedure. However, like the SAM procedure
it is not designed to control the FDR and was observed to not control FDR when m0/m is large.
These results are encouraging.
4. Analysis of the Breast Cancer Data
We analyze a publicly available cDNA microarray dataset from a study of breast cancer reported by
Van’t Veer et al. (2002). The data consist of approximately 25,000 gene expression measurements
from 44 cases found to have good prognosis cases and 34 who had a poor prognosis. The goal of
the study is to identify a subset of genes that are predictive of the prognostic status of breast cancer
patients. Although Van’t Veer et al proceeded to combine data across genes for prediction, we are
concerned here only with the first step to select a set of genes which are each associated with prognosis.
The gene expression measurement is the logarithm of the ratio of the intensities of the red to green
fluorescent dyes, where green dye is used for the reference pool and red is used for the experimental
tissue. In the study of Van’t Veer et al. (2002), as a first step the authors selected some 5000 genes
by applying gene filtering techniques that are described in the paper. To investigate properties of our
new multiple testing procedure, we follow the same gene filtering procedure and obtain a sample of
4866 genes. We use the AUC test statistic to describe how well a gene discriminates those subjects
that develop distant metastases within 5 years (poor prognosis status) from those who are disease free
beyond 5 years (good prognosis status). Figure 6 displays the distribution of the AUCs for the 4866
genes. The AUC statistics for most of the genes are between 0.5 to 0.6, indicating that the majority
of the genes are not differentially expressed.
We first calculate the unadjusted p-value for each gene using the Wilcoxon rank-sum test, the test
11
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that uses the AUC value as its test statistic. 839 out of 4866 genes (17.24%) have a p-value less than
0.05, suggesting that the problem with multiple comparisons may be quite substantial here. If we
perform the Bonferroni adjusted procedure, only two genes have an adjusted p-value less than 0.05.
We performed the BH linear step-up procedure, the adaptive procedure and our new AP procedure.
For the adaptive procedure, we obtain an estimatedm0/m = 0.70 with a smoothing method suggested
by Storey(2003). For the AP method, the adjusted p-values are calculated based on 1000 random
permutations. Figure 7 displays the p-values for the top 200 genes using the above multiple testing
procedures along with the unadjusted p-values. When we choose to reject genes at the 0.05 level,
four genes are rejected by the BH procedure, 7 genes are claimed as significant by both the AP and
the adaptive procedures. When we choose to reject on the basis of α < 0.1, we find that 133, 197
and 317 genes are selected by the BH, AP and the adaptive procedures respectively. These results
are consistent with our numerical finding that the adaptive procedure is usually the most powerful
procedure. Assuming that our simulation study results apply to this dataset, with m0/m = 0.70,
the FDR is controlled at level less than or equal to α for the BH or AP procedures, however for the
adaptive procedure FDR could be potentially higher than α depending on the correlation structure
of the data. This means that for the new procedure, among the 4866 genes we considered, on average
at most 20 genes out of the 197 genes could be false positive. If we can afford the time and costs that
are spent in vain on the 20 genes, we may benefit from studying a relatively bigger pool of potentially
informative genes. In this particular dataset, our new algorithm appears to be effective.
We next compare the AP procedure with SAM. The SAM software allows one to interactively
change ∆ to control FDR if desired. Storey (2001) argues that a positive FDR, pFDR = E
[
V (∆)
R(∆) |R(∆) > 0
]
,
may be a better quantity than ∆ since it provides more meaningful interpretation. Corresponding
to the pFDR, he suggests estimating q value, the probability that a null gene is true conditioning on
observing a statistic as extreme or more extreme. We note that although our AP value and q-value
have different interpretations, both are individual measures that take into account the problem with
multiplicity, and both can be used to calibrate differential gene expression. We thus compare our
AP values with q-values reported by the SAM software. To facilitate the comparison for a gene j
we consider a statistic dj , that is based on the two sample t-statistic, but with a small constant s0
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added to the denominator, following the SAM procedure. Among the top 200 genes ranked on d(j),
j = 1, . . . , 200, more significant genes will be identified if we choose to draw the line based on the q
values of the SAM procedure, compared with the selection procedure using the same AP value (top
panel Figure 8). On the other hand, the AP values appear to be more fine tuned with the test statis-
tics. As can be seen in the bottom panel of Figure 8, the AP value (without the final monotonization)
decreases gradually as the value of the test statistic increases. Unlike the q-value which assign equal
values to SAM scores range 3.5 to 5, AP values acknowledge such differences and gives distinct p
values to the scores in that spectrum. In summary, the SAM procedure appears to be more powerful
as it discovers more significant genes given the same significant level. However, the AP procedure is
also attractive as it corresponds more closely with the values of the statistics under consideration.
Furthermore, the estimation procedure for AP values are simpler than that for the q-values which
also rely on more assumptions about the dependence structures and require m0/m and pFDR be well
estimated.
5. Discussion
This manuscript concerns the issue of selecting a subset of genes that are differentially expressed.
We propose a new approach that to deciding which genes to select for further study. Genes are
ranked according to some statistic and the procedure dictates at which k to draw the line.Genes
above k are pursued further. statistically more rigorously select top k genes. Similar to many of the
existing multiple hypothesis testing procedures, we take into account the problem of multiplicity by
calculating adjusted p-values for all genes simultaneously and reject genes if their adjusted p-values
do not exceed a predetermined value α. Similar to SAM, these adjusted p-values are computed based
on the distributions of order statistics under Hc0.
A strength of the approach we have presented is that the methodology can accommodate many
complications such as dependence amongst genes. Although the proposed method does not directly
control FDR, our simulation studies show that rejection based on the new adjusted p-value method is
as powerful as those methods that aim to control FDR, given the same FDR level. However, for many
of the existing FDR controlling procedures to perform well, certain assumptions about correlation
structures are needed. These assumptions may or may not hold in practice. Furthermore, although
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the proposed method is in spirit similar to the SAM procedure, our procedure has intuitive appeal
and it acknowledges that the distribution of jth order statistic may not be symmetric about its mean
and that its variance may depend on the order (j). Indeed, our simulation study shows that for small
sample sizes where SAM is expected to perform well, our proposed method is more powerful than
SAM if the gene expression levels are not symmetrically distributed.
Our study also leads to some interesting findings on the operating characteristics of our new
method and some existing multiple hypothesis testing procedures. In the diagnostic testing setting,
it is well known that increasing TPR usually is accompanied by decreasing 1-FPR. A similar trade-off
can be observed in the relationship between AP and FDR at least based on our simulation studies.
With the emergence of many new methods for choosing rejection regions in a microarray study, it is
important in our opinion to take into consideration this aspect of the operating characteristics when
the performance of a new method is evaluated.
14
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Figure 1: Simulation results for the AP and SAM procedures with expression levels from normal
distributions. Top panels show data with n0 = n1 = 20, bottom panels show data with n0 = n1 = 50.
Left panel shows data with ROC curves. Right panel shows Average power versus FDR.
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Figure 2: Simulation results for the AP and SAM procedures with expression levels from gamma
distributions. Top panels show data with n0 = n1 = 20, bottom panels show data with n0 = n1 = 50.
Left panel shows data with ROC curves. Right panel shows Average power versus FDR.
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Figure 3: FDR versus α for m=40, nD = nD¯ = 20. Each row corresponds to a different correlation
structure. The first column presents results from simulations with m0/m = 50%, the second column
with m0/m = 75%, and the third column with m0/m = 90%. The solid diagonal line represents
the benchmark where FDR is equal to the trhreshold α for declaring genes as differentially expressed
using the multiple testing procedure.
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Figure 4: FDR versus α for m=40, nD = nD¯ = 20. Each row corresponds to a different correlation
structure. The first column presents results from simulations with m0/m = 50%, the second column
with m0/m = 75%, and the third column with m0/m = 90%.
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Figure 5: Average Power versus FDR from simulation studies with m=200 and m=1000. Separate
lines are fitted with smoothing splines for m0 = 50%m(the line on top), m0 = 75%m(the line in the
middle), and m0 = 90%m(the line at the bottom).
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Figure 6: Histogram of AUC for 4866 genes from the breast cancer study
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Figure 7: P values from different multiple testing procedures for the top 200 genes from the breast
cancer study. The first horizontal solid line indicates reject region for α = 0.1, the second line is for
α = 0.075, the third line is for α = 0.05. |s represents the distribution of AUC.
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Figure 8: Comparison of the AP procedure with SAM using the breast cancer data. Top panel shows
the p-values from the AP procedure (solid line) or the q-value from the SAM procedure (dotted
line) for the top 200 genes. Bottom panel shows adjusted p-values/q values versus the test statistics
(d-scores) from SAM for the top 200 genes.
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Table 1: Outcomes from multiple tests with m genes
# not rejected #rejected
# H0 U V m0
# Ha T S m1
total m-R R m
Table 2: Simulation studies for m=200, r1=0, r2=0.
α FDR Average Power
AP BH Adapt AP BH Adapt
m0 = 50%m
0.01 0.007 0.005 0.010 0.866 0.859 0.877
0.05 0.032 0.027 0.051 0.907 0.902 0.919
0.1 0.061 0.052 0.100 0.923 0.920 0.936
0.2 0.116 0.103 0.199 0.940 0.937 0.955
m0 = 75%m
0.01 0.010 0.008 0.010 0.846 0.836 0.845
0.05 0.045 0.037 0.049 0.889 0.883 0.891
0.1 0.090 0.074 0.100 0.908 0.903 0.910
0.2 0.172 0.149 0.198 0.927 0.923 0.931
m0 = 90%m
0.01 0.013 0.006 0.007 0.489 0.401 0.414
0.05 0.066 0.039 0.048 0.662 0.608 0.621
0.1 0.127 0.089 0.102 0.728 0.689 0.699
0.2 0.239 0.177 0.199 0.797 0.762 0.775
Table 3: Simulation studies for m=200, r1=0.6, r2=0.6.
α FDR Average Power
AP BH Adapt AP BH Adapt
m0 = 50%m
0.01 0.007 0.006 0.012 0.964 0.963 0.968
0.05 0.031 0.026 0.057 0.976 0.975 0.980
0.1 0.061 0.0527 0.111 0.981 0.980 0.985
0.2 0.117 0.104 0.214 0.986 0.985 0.990
m0 = 75%m
0.01 0.009 0.007 0.010 0.959 0.957 0.959
0.05 0.044 0.036 0.051 0.973 0.971 0.974
0.1 0.087 0.071 0.103 0.978 0.976 0.979
0.2 0.172 0.148 0.206 0.983 0.982 0.984
m0 = 90%m
0.01 0.014 0.007 0.008 0.844 0.811 0.818
0.05 0.068 0.042 0.051 0.900 0.885 0.891
0.1 0.128 0.088 0.104 0.923 0.909 0.913
0.2 0.237 0.181 0.214 0.944 0.935 0.940
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Table 4: Simulation studies for m=200, r1=0.6, r2=-0.6.
α FDR Average Power
AP BH Adapt AP BH Adapt
m0 = 50%m
0.01 0.007 0.005 0.008 0.591 0.583 0.595
0.05 0.031 0.025 0.038 0.644 0.636 0.651
0.1 0.062 0.053 0.078 0.671 0.664 0.681
0.2 0.116 0.102 0.150 0.703 0.696 0.718
m0 = 75%m
0.01 0.010 0.007 0.009 0.572 0.562 0.568
0.05 0.045 0.037 0.043 0.621 0.613 0.620
0.1 0.090 0.074 0.089 0.646 0.639 0.646
0.2 0.177 0.153 0.183 0.675 0.669 0.676
m0 = 90%m
0.01 0.016 0.007 0.007 0.356 0.305 0.311
0.05 0.065 0.041 0.043 0.447 0.414 0.420
0.1 0.125 0.083 0.089 0.486 0.462 0.467
0.2 0.242 0.170 0.185 0.540 0.510 0.517
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